Skip to main navigation Skip to search Skip to main content

Resistance of BRAFV600E-mutant melanoma to Vemurafenib: a senescence-induced swing from differentiation to blastulation followed by proliferation

  • Felikss Rumnieks
  • , Ninel M. Vainshelbaum
  • , Kristīne Salmiņa
  • , Maria Lazovska
  • , Madara Kreismane
  • , Dace Pjanova
  • , Justs Zalums
  • , Kristīne Vaivode
  • , Daniel Ross Saliba
  • , Pawel Zayakin
  • , Talivaldis Freivalds
  • , Dmitry Perminov
  • , Andrzej Kasperski
  • , Harry Scherthan
  • , Mark Steven Cragg
  • , Jekaterina Ērenpreisa (Corresponding Author)

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

Resistance to Vemurafenib (VEM), a targeted BRAFV600E inhibitor, was examined in the metastatic paratetraploid (XX, abnormal Y chromosome) melanoma cell line, SkMel28. During the first week of treatment, pERK suppression coincided with transcriptomic and phenotypic changes related to senescence, autophagy/mitophagy, neuro-melanogenesis, and cell co-alignment. By the second week, MAPK–ERK signalling was restored, coinciding with surmounting the G1/S checkpoint, G2M checkpoint delay, mitotic slippage (MS), and downregulation of senescence and melanogenesis. The dynamics of melanogenesis and MS were highly correlated. By days 12–15, ∼8% of cells with melanin remnants exhibited hyperploidy and multinucleation, some arranged as rosettes, encased by a Zona pellucida-positive structure reminiscent of oocytes, zygotes, or blastulae, occasionally yielding cellularised sub-cells or stalling in diapause. These parasexual processes eventually ceased; cells resumed proliferative clonogenic growth and their initial mito-meiotic, mesenchymal profile. Transcriptomic analysis confirmed the reversal of their cell fate direction: from senescence-induced neuro-melanogenesis to its suppression and activation of female meiosis–like and mitosis states. The transition point of this cell-fate reversal coincided with S-phase resumption, highlighted by replication delay and activation of the FOS–TEAD/Hippo axis of the “female pregnancy” (stress-response, embryonal placentation, vascularisation, stemness, anti-apoptosis) gene ontology module. We conclude that resistance to VEM in SkMel28 cells encompasses the transition between three possible cell fates: (1) senescence/differentiation, (2) reprogramming/blastulation, and (3) recovery of the proliferative mito-meiotic profile. The coexpression of senescence, reprogramming and gametogenetic genes in a dataset of late-stage melanoma patient samples supports these results.

Original languageEnglish
Article number218430
JournalCancer Letters
Volume646
DOIs
Publication statusPublished - 28 May 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords*

  • Blastulation
  • BRAF-V600E melanoma
  • Invasion
  • Reprogramming
  • Resistance
  • Senescence
  • Vemurafenib

Field of Science*

  • 1.6 Biological sciences
  • 3.1 Basic medicine
  • 3.5 Other medical sciences

Publication Type*

  • 1.1. Scientific article indexed in Web of Science and/or Scopus database

Fingerprint

Dive into the research topics of 'Resistance of BRAFV600E-mutant melanoma to Vemurafenib: a senescence-induced swing from differentiation to blastulation followed by proliferation'. Together they form a unique fingerprint.

Cite this